Restricting pharmaceutical patent rights to realise the right of access to healthcare under the constitution

Abstract

Are the restrictive legislative mechanisms of the Patents Act and the Competition Act sufficient to enable the State to fairly regulate the exercise of pharmaceutical patent rights in trying to realise the right to healthcare under section 27 of the Constitution, without undermining such patent rights